71 in-depth guides in this cluster
The EU Medical Device Regulation (MDR 2017/745) is the legal framework governing how medical devices are designed, manufactured, and sold in Europe — here is what startups need to know.
The EU MDR replaced the MDD with stricter classification, clinical evidence, and oversight requirements — here are the specific changes that affect MedTech startups.
Every critical MDR milestone from adoption in 2017 through the extended transition periods — a complete timeline for MedTech startups planning their regulatory path in 2026.
A practical method for MedTech startup founders to read, understand, and work with the EU MDR (2017/745) without getting lost in 175 articles and 17 annexes.
Article 2 of the EU MDR contains over 70 definitions that determine your regulatory path — here are the 50 most critical terms for MedTech startups, explained in plain language.
The MDR definition of a medical device in Article 2(1) determines whether your product is regulated — here is exactly how to apply it to your startup's product.
The MDR scope in Article 1 defines which products are regulated — here is how to determine if your startup's product falls under the EU Medical Device Regulation.
The line between a medical device and a wellness product under EU law depends on intended purpose — here is how to determine which category your startup's product falls into.
Many startup products sit on the boundary between medical device and non-medical product — here is how to determine your product's regulatory status under the EU MDR.
Launching your product as a wellness device before pursuing MDR certification is a legitimate go-to-market strategy — here is how to do it correctly and what traps to avoid.
Annex I of the MDR contains the General Safety and Performance Requirements (GSPRs) that every medical device must meet — here is how startups should approach them systematically.
The MDR replaced the MDD's Essential Requirements with General Safety and Performance Requirements (GSPRs) — here are the specific changes and what they mean for your compliance strategy.
The MDR ecosystem includes competent authorities, Notified Bodies, the European Commission, and the MDCG — here is who they are, what they do, and how they affect your startup.
Notified Bodies are the organizations that audit your medical device and issue your CE marking certificate — here is how they work, what they look for, and how to prepare.
Choosing the right Notified Body affects your timeline, costs, and audit experience — here is how to evaluate and select the best Notified Body for your startup's device.
Notified Body capacity constraints create 6-18 month wait times for MDR certification — here are practical strategies for startups to manage and mitigate the bottleneck.
Competent authorities enforce the MDR in each EU member state — here is what they do, how they affect your startup, and when you need to interact with them.
The European Commission shapes MDR implementation through EUDAMED, common specifications, harmonized standards, and implementing acts — here is what startups need to know.
MDR Article 5 defines the conditions for placing medical devices on the EU market — here is what it requires and how startups should prepare for market entry.
The MDR definition of 'manufacturer' in Article 2(30) carries extensive legal obligations — here is what it means for startup founders who outsource production or use contract manufacturers.
Non-EU manufacturers must appoint an authorized representative under MDR Article 11 to place medical devices on the EU market — here is when you need one and how to select the right partner.
Importers and distributors have specific MDR obligations that affect how startups structure their sales channels — here is what each role requires and how it impacts your go-to-market strategy.
MDR Article 15 requires every manufacturer to designate a Person Responsible for Regulatory Compliance (PRRC) with specific qualifications — here is what startups need to know.
Startups qualifying as micro or small enterprises can use an external PRRC under MDR Article 15 — here are the practical options, costs, and trade-offs for meeting this requirement.
The MDR transition periods have been extended by Regulation (EU) 2023/607 — here is what still applies in 2026, which deadlines are approaching, and how they affect your startup.
Complete breakdown of the MDR amendment (EU) 2023/607 that extended transition periods for legacy medical devices. Learn what changed, new deadlines, and what it means for your MedTech startup.
The complete step-by-step CE marking process under EU MDR 2017/745 for medical device startups. From device classification to declaration of conformity — every stage explained from the startup perspective.
Realistic CE marking timelines for medical device startups under EU MDR. Honest breakdowns by device class, with typical delays and what actually drives the timeline.
Transparent cost breakdown for CE marking under EU MDR for medical device startups. Real numbers for QMS, testing, Notified Body fees, clinical evaluation, and regulatory consulting by device class.
How MedTech startups with limited budgets and small teams can build a lean but compliant regulatory strategy to reach CE marking under EU MDR. Practical frameworks for prioritizing what matters.
Complete guide to MDR conformity assessment procedures under Annexes IX, X, and XI. How to choose the right route for your medical device class and why it matters for startups.
When and how medical device startups can self-certify under EU MDR without a Notified Body. Class I self-certification requirements, responsibilities, and common pitfalls explained.
How to write the EU Declaration of Conformity under MDR Annex IV. Required content, format guidance, common mistakes, and practical templates for medical device startups.
What free sale certificates are, when MedTech startups need them, how to obtain them, and their role in international market access beyond the EU under MDR.
MDR rules for custom-made medical devices explained for startups. Understand the definition, documentation requirements, and conformity path for personalized and patient-specific devices.
Complete guide to MDR Annex XVI devices — products with no medical purpose that fall under medical device regulation. Aesthetic devices, colored contact lenses, brain stimulation, and more.
What Common Specifications are under EU MDR, when they apply, how they differ from harmonized standards, and what MedTech startups need to know to comply.
Complete overview of harmonized standards under EU MDR in 2026. Which standards are harmonized, how to check their status, and what the gaps mean for MedTech startups.
Practical guide for MedTech startups on using harmonized standards to demonstrate compliance with EU MDR General Safety and Performance Requirements. GSPR mapping, documentation, and Notified Body expectations.
What 'state of the art' means under EU MDR, how it affects medical device design, and how startups can demonstrate they meet this critical requirement.
Deep dive into MDR Article 61 clinical evidence requirements for medical devices. What startups get wrong about clinical evaluation, equivalence, and clinical investigations.
How Notified Body auditors evaluate 'sufficient clinical evidence' under EU MDR. Insider perspective on what passes, what fails, and what startups can do to meet the bar.
What happens when a medical device manufacturer violates EU MDR. Market surveillance actions, penalties, recalls, and enforcement consequences explained for startups.
The 10 most frequent non-conformities Notified Body auditors find in MedTech startup audits under EU MDR. What they are, why they happen, and how to prevent them.
How EU MDR regulates medical device accessories. Definition, classification rules, and compliance requirements for startups building add-on products that work with medical devices.
How EU MDR handles combination products — drug-device and biologic-device combinations. Regulatory pathways, classification, and practical guidance for MedTech startups.
How Brexit changed medical device regulation for EU startups selling to the UK. UKCA marking, CE marking recognition, UK Approved Bodies, and practical market access strategies.
Side-by-side comparison of UKCA marking and CE marking for medical devices. Key differences, practical implications, and dual-marking strategies for EU MedTech startups.
Side-by-side comparison of EU MDR and US FDA medical device regulation. Key differences in classification, approval pathways, clinical evidence, and post-market requirements for startups.
How MedTech startups can build a regulatory strategy for simultaneous EU MDR and US FDA market access. Dual-market planning, documentation synergies, and practical sequencing advice.
Documenting everything MDR-compliant from day one kills startup speed. The two-phase approach: prove feasibility first, then certify what works.
The right time to start MDR work is not day one and not after prototype. It is the moment your intended purpose stabilizes. Here is the founder's timeline.
What do Notified Body auditors actually look for during an MDR audit? A lead auditor and founder explains what matters and what doesn't.
Your first notified body audit is not an exam. It is a structured conversation about whether your QMS and technical file match reality. Here is how to prepare.
Stage 1 is a documentation and readiness review. Stage 2 is the on-site operational assessment. Here is what happens in each, and how to prepare.
Notified Bodies are required to carry out unannounced on-site audits of manufacturers under MDR. Here is what they look for and how to stay audit-ready every day.
Your Notified Body audit came back with nonconformities. Here is the CAPA response process that closes them out without triggering new findings.
What does MDR look like from both sides of the audit table? Tibor Zechmeister has spent 15 years as a founder and as a lead auditor. Here is what that dual view teaches.
What changed in the MDR landscape at the turn of 2026: MDCG 2025-10 on PMS, ISO 10993-1:2025, the ISO 14155 amendment, and what they mean for startups.
What is coming in the MDR landscape in 2027: the end of transitional provisions, the MDR review cycle, pending MDCG guidance, and how founders should prepare now.
Fifteen MDR myths that show up in almost every first meeting with a MedTech founder — and the regulatory reality behind each one, with the article references.
When should a MedTech startup do MDR work in-house and when should they hire a consultant? A decision framework plus how to spot charlatans.
A direct, honest guide to MDR compliance for first-time MedTech founders. No jargon, no fluff, no hidden complexity. The real path from zero to CE mark.
Your MDR regulatory roadmap is the sequence of decisions and deliverables from intended purpose to CE mark. Here is the template that actually works for startups.
The Subtract to Ship framework applied to MDR: strip every activity, document, and feature that does not trace back to a specific MDR article. Less work, more certification.
MDCG guidance is not legally binding, but notified bodies treat it as the reference interpretation of MDR. Here's how the legal hierarchy actually works.
Non-EU guidance documents are not recognised under MDR but can support state-of-the-art arguments. Here is when FDA, IMDRF and AAMI help and when they don't.
National laws on top of MDR add language, advertising, clinical investigation, and reimbursement rules across EU Member States. Plan for the patchwork.
Placing on market vs putting into service MDR: Article 2(28), 2(29), 2(31) definitions drive transitional provisions and deadlines for your device.
Switching notified bodies MDR Article 58: the voluntary change process, the agreement-between-NBs requirement, and how to avoid certification gaps.
The December 2025 European Commission proposal on MDR deregulation signals partial relief for low-risk devices. Here is what it does and does not change.